SCOTT DORFMAN

Concepts (100)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Societies, Medical
8
2020
696
0.430
Why?
Appendicitis
3
2019
128
0.260
Why?
Drowning
1
2024
41
0.220
Why?
Pneumonia
2
2020
324
0.210
Why?
Lung Injury
1
2024
122
0.210
Why?
Radiology
2
2020
106
0.190
Why?
Hydronephrosis
1
2020
35
0.170
Why?
Foot Injuries
1
2020
7
0.170
Why?
Near Drowning
1
2020
26
0.160
Why?
Radiography, Thoracic
1
2020
151
0.160
Why?
Hip Dislocation, Congenital
1
2019
18
0.160
Why?
Bone Diseases
1
2018
44
0.150
Why?
Evidence-Based Medicine
5
2020
635
0.150
Why?
Hematuria
1
2018
54
0.140
Why?
Peer Review, Health Care
1
2017
17
0.140
Why?
Medical Informatics Applications
1
2017
20
0.140
Why?
Leg
1
2018
158
0.140
Why?
Radiology Department, Hospital
1
2017
24
0.140
Why?
Movement Disorders
1
2018
222
0.130
Why?
Learning
1
2017
361
0.110
Why?
Diagnostic Imaging
3
2020
277
0.110
Why?
United States
8
2020
10918
0.110
Why?
Bronchial Diseases
1
2013
11
0.100
Why?
Granuloma, Plasma Cell
1
2013
7
0.100
Why?
Urinary Tract Infections
1
2017
298
0.100
Why?
Infant
8
2024
12504
0.100
Why?
Diagnosis, Differential
5
2019
1896
0.100
Why?
Quality Improvement
1
2017
643
0.090
Why?
Ultrasonography
4
2020
941
0.090
Why?
Infant, Newborn
6
2024
8225
0.090
Why?
Child
12
2024
24402
0.090
Why?
Contrast Media
3
2019
480
0.090
Why?
Infarction
2
2001
23
0.090
Why?
Omentum
2
2001
47
0.090
Why?
Child, Preschool
7
2024
14019
0.070
Why?
Acute Disease
4
2018
1110
0.070
Why?
Humans
18
2024
125167
0.060
Why?
Cross-Sectional Studies
2
2024
3429
0.050
Why?
Granulomatous Disease, Chronic
1
2004
66
0.050
Why?
Failure to Thrive
1
2004
90
0.050
Why?
Environmental Exposure
1
2004
220
0.050
Why?
Recurrence
2
2017
1420
0.050
Why?
Male
10
2024
61503
0.050
Why?
HIV-1
1
2004
464
0.040
Why?
Adolescent
4
2024
19350
0.040
Why?
Abdominal Pain
1
2001
309
0.040
Why?
Female
8
2024
66783
0.040
Why?
Cytarabine
2
1996
97
0.040
Why?
Radiology Information Systems
1
2017
23
0.040
Why?
Emergency Service, Hospital
1
2024
1066
0.030
Why?
Radionuclide Imaging
1
2017
149
0.030
Why?
Workflow
1
2017
118
0.030
Why?
Family
1
2020
566
0.030
Why?
Glomerulonephritis
1
2017
73
0.030
Why?
Renal Veins
1
1996
36
0.030
Why?
Vesico-Ureteral Reflux
1
2017
81
0.030
Why?
Leukocytosis
1
1996
46
0.030
Why?
Leukemia, Myeloid
1
1996
85
0.030
Why?
Epiglottitis
1
1995
12
0.030
Why?
Whole-Body Irradiation
1
1995
64
0.030
Why?
Enterobius
1
1995
1
0.030
Why?
Entamoeba histolytica
1
1995
14
0.030
Why?
Ascaris lumbricoides
1
1995
19
0.030
Why?
Trichuris
1
1995
26
0.030
Why?
Sensitivity and Specificity
1
2020
2056
0.030
Why?
Radiation Injuries
1
1995
142
0.030
Why?
Sex Factors
1
2017
1288
0.030
Why?
Kidney
2
2017
1365
0.030
Why?
Activin Receptors, Type II
1
2013
31
0.030
Why?
Bone Marrow Transplantation
1
1995
575
0.020
Why?
HIV Infections
1
2004
1897
0.020
Why?
Thrombosis
1
1996
525
0.020
Why?
Retrospective Studies
3
2024
16342
0.020
Why?
Gene Rearrangement
1
2013
320
0.020
Why?
Risk Factors
1
2024
10309
0.020
Why?
Leukocyte Count
2
2001
250
0.020
Why?
Prevalence
1
1995
2456
0.020
Why?
Pregnancy
1
2020
7202
0.020
Why?
Aged, 80 and over
1
1995
6600
0.010
Why?
NADPH Oxidases
1
2004
114
0.010
Why?
Tomography, X-Ray Computed
2
2004
2106
0.010
Why?
Phosphoproteins
1
2004
417
0.010
Why?
Body Temperature
1
2001
118
0.010
Why?
Appendectomy
1
2001
86
0.010
Why?
Diagnostic Errors
1
2001
334
0.010
Why?
Aged
1
1995
19871
0.010
Why?
Thioguanine
1
1996
21
0.010
Why?
Daunorubicin
1
1996
27
0.010
Why?
Leukapheresis
1
1996
13
0.010
Why?
Laparoscopy
1
2001
493
0.010
Why?
Atrophy
1
1996
230
0.010
Why?
Epiglottis
1
1995
9
0.010
Why?
Ultrasonography, Doppler
1
1996
195
0.010
Why?
Middle Aged
1
1995
26932
0.010
Why?
Adult
1
1995
29634
0.010
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
1995
127
0.010
Why?
Animals
1
1995
34219
0.010
Why?
Combined Modality Therapy
1
1995
1241
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1254
0.000
Why?
Prospective Studies
1
1999
6159
0.000
Why?
DORFMAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_